Radiotherapy and Temsirolimus vs Radiochemotherapy With Temozolomide for Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Phase II Study of Radiotherapy and Temsirolimus Versus Radiochemotherapy With Temozolomide in Patients With Newly Diagnosed Glioblastoma Without MGMT Promoter Hypermethylation (EORTC 26082)
Clin. Cancer Res 2016 May 03;[EPub Ahead of Print], W Wick, T Gorlia, P Bady, M Platten, MJ van den Bent, MJ Taphoorn, J Steuve, AA Brandes, MF Hamou, A Wick, M Kosch, M Weller, R Stupp, P Roth, V Golfinopoulos, JS Frenel, M Campone, D Ricard, C Marosi, S Villa, A Weyerbrock, K Hopkins, K Homicsko, B Lhermitte, GA Pesce, ME HegiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.